Browse EX-10 agreements

**EXECUTION VERSION **

**CREDIT AGREEMENT **

dated as of September 14, 2026

by and among

STEPSTONE SPV FACILITY VII LLC,

**as Borrower, **

STEPSTONE PRIVATE CREDIT FUND LLC,

**as Collateral Manager **

VARIOUS LENDERS,

GOLDMAN SACHS BANK USA,

**as Syndication Agent **

GOLDMAN SACHS BANK USA,

**as Administrative Agent **

GOLDMAN SACHS BANK USA,

**as Calculation Agent **

UMB BANK, NATIONAL ASSOCIATION,

**as Collateral Agent **

UMB BANK, NATIONAL ASSOCIATION,

**as Collateral Custodian **

UMB BANK, NATIONAL ASSOCIATION,** **

**as Collateral Administrator **

---

**TABLE OF CONTENTS **

…

**EXECUTION VERSION **

This **NON-RECOURSE CARVEOUT GUARANTY AGREEMENT **(this “Agreement”) is entered into as of September 14, 2026 (the “Closing Date”), by and among STEPSTONE SPV FACILITY VII INTERMEDIATE HOLDCO LLC, a Delaware limited liability company (the “Parent Guarantor”), and STEPSTONE PRIVATE CREDIT FUND LLC, a Delaware limited liability company (the “Fund Guarantor” and, together with the Parent Guarantor, each, a “Guarantor Entity” and, together with any additional guarantor entity made party from time to time to this Agreement, the “Guarantor Entities”), in favor of (a) UMB BANK, NATIONAL ASSOCIATION, as collateral agent (together with its successors and assigns in such capacity, the “Collateral Agent”) for and on behalf of the Secured Parties (as defined in the Credit Agreement referred to below), and (b) GOLDMAN SACHS BANK USA and its affiliates that are successors and assigns, as Lender, Administrative Agent and Calculation Agent (each as defined in the Credit Agreement referred to below).

…

---

Exhibit 10.2

SECURITIES PURCHASE AGREEMENT

This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of September 17, 2026, by and among Lisata Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the Persons listed on Exhibit A attached to this Agreement (each, an “Investor” and together, the “Investors”).

WHEREAS, the Company and the Investors are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act;

…

---

Exhibit 10.1

REGISTRATION RIGHTS AGREEMENT

This Registration Rights Agreement (this “Agreement”) is dated as of September 17, 2026, by and between Lisata Therapeutics, Inc., a Delaware corporation (the “Company”), and the undersigned signatories hereto.

This Agreement is made in connection with that Agreement and Plan of Merger, dated as of the date hereof, by and among the Company, Marea Therapeutics, Inc., a Delaware corporation (“Marea”), Mariner Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“First Merger Sub”), and Mariner Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company (“Second Merger Sub”) (as amended, restated, supplemented or otherwise modified from time to time, the “Merger Agreement”), pursuant to which the Company has agreed to issue shares of the Company’s Series C Non-Voting Convertible Preferred Stock, par value $0.01 per share (the “Preferred Shares”) and/or shares of Common Stock (as defined below, and collectively with the Preferred Shares, the “Shares”), to the equit

…

---

Exhibit 10.3

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT(this “Agreement”), dated as of September 17, 2026, is entered into by and among Lisata Therapeutics, Inc., a Delaware corporation (the “Company”), and the several investors signatory hereto(individually as an “Investor” and collectively together with their respective permitted assigns, the “Investors”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement by and among the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).

WHEREAS:

…

EXECUTIVE EMPLOYMENT AGREEMENT

THIS EXECUTIVE EMPLOYMENT AGREEMENT (hereinafter “Agreement”) is made and entered into effective as of August 28, 2026, by and between PETMED EXPRESS, INC., a Florida corporation (“Company”), and JEFFREY ALLEN WILLARD, an individual (hereinafter called “Executive”).

RECITALS

WHEREAS, Company desires to retain the services of Executive as Chief Executive Officer and President of Company upon the terms and subject to the conditions set forth in this Agreement; and

WHEREAS, Executive desires to provide services to Company pursuant to the terms and conditions set forth in this Agreement

NOW THEREFORE, in consideration of the mutual covenants and promises set forth in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be legally bound, agree as follows:

1.    DUTIES AND SCOPE OF EMPLOYMENT.

…

Personal Employment Agreement

** **

This Personal Employment Agreement (this “Agreement”) is made as of September 15, 2026, by and between Duke Robotics Corp. a US Nevada State registered corporation, with offices at of 10 HaRimon Street, Mevo Carmel Science and Industrial Park, Israel (the “Company” or “Duke”) and **Avi Levin **(ID No.__________) (the “Executive”) of _____________________, Israel.

…

EMPLOYMENT AGREEMENT

This EMPLOYMENT AGREEMENT (this “Agreement”), dated as of this 13th day of September, 2026 (the “Effective Date”), is by and between Colony Bank (“Employer”), a Georgia Bank and wholly-owned subsidiary of Colony Bankcorp, Inc. (the “Holding Company”) and R. Dallis Copeland (“Employee”), a resident of the State of Georgia (collectively, the “Parties”).

WHEREAS, Employee is currently engaged as the President of both the Holding Company and Employer;

WHEREAS, the Holding Company, Employer and Employee desire to enter an employment agreement to memorialize the terms of Employee’s employment; and

NOW, THEREFORE, in consideration of the mutual covenants herein contained, Employer and Employee hereby agree as follows:

	1.	Employment.

(a)Agreement to Employ. Upon the terms and subject to the conditions of this Agreement, Employer hereby agrees to employ Employee and Employee hereby agrees to be employed with Employer as of the Effective Date.

…

FORM OF COMPANY SUPPORT AGREEMENT

This Support Agreement (this “Agreement”) is made and entered into as of September 17, 2026, by and among North Immunology Inc., a Delaware corporation (the “Company”), Aethlon Medical, Inc., a Nevada corporation (“Parent”), and the undersigned stockholder of the Company (the “Stockholder” and each of the Stockholder, Company, and Parent, a “Party” and, collectively, the “Parties”). Capitalized terms used herein but not otherwise defined shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).

RECITALS

…

FORM OF CONTINGENT VALUE RIGHTS AGREEMENT

This CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated as of [__], 2026, is entered into by and among Aethlon Medical, Inc., a Nevada corporation (the “Company”), [__], a [__], as the “Rights Agent” (as defined herein), and Nicolas Gikakis, an individual, solely in his capacity as the initial representative, agent and attorney in fact of the Holders (the “Representative”).

RECITALS

…

SECURITIES PURCHASE AGREEMENT

This SEC****URITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of September 17, 2026, by and among North Immunology Inc., a Delaware corporation (the “Company”), and each of the Persons listed on Exhibit A attached to this Agreement (each, an “Investor” and together, the “Investors”).

WHEREAS, the Company and the Investors are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the U.S. Securities Act of 1933, as amended (the “Securities Act”);

…